Infantile Hemangiomas Treated by Sequential Application of Pulsed Dye Laser and Nd:YAG Laser Radiation: A Retrospective Study

Alcántara‐González, J.; Boixeda, P.; Truchuelo-Díez, M.T.; Pérez‐García, B.; Alonso-Castro, Leticia; Olásolo, Pedro Jaén

doi:10.1016/j.adengl.2012.12.004

Cited by 24 publications

(53 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The classification and roughly the size of IH corresponded to data reported before . In our collective, patients’ ages at the time of the first treatment ranged between one and 533 weeks with a median age of 24 weeks, which is similar to other studies …”

Section: Discussionsupporting

confidence: 89%

“…The long‐pulsed neodymium‐doped yttrium aluminium garnet laser (Nd:YAG, wavelength 1064 nm) reaches deeper dermal structures of up to 10 mm and offers an effective, well‐established and safe method for treating deep and large vascular lesions . So far, sequential application of Nd:YAG laser and PDL has been shown to be effective in the treatment of IH in 25, 22 and 38 patients, respectively …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children

Hartmann

Lockmann

Grönemeyer

et al. 2017

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Introductionmentioning

confidence: 99%

Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children

Hartmann

Lockmann

Grönemeyer

et al. 2017

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…The first pulse is with the highly absorbed 595-nm laser, followed milliseconds later by the deeper-penetrating 1,064-nm laser. Studies using this device have shown this combination to be effective for the treatment of hemangiomas at all stages of development [18]. Alster and Tanzi [19] treated recalcitrant port-wine stains in 25 patients.…”

Section: Hemangiomasmentioning

confidence: 99%

Nd:YAG Laser

Kaufman¹

2014

Laser Treatment of Vascular Lesions

View full text Add to dashboard Cite

The Nd:YAG laser, with its 1,064-nm wavelength, is a mainstay for treatment of vascular lesions. What it may sacrifice in absorption by hemoglobin, it makes up for in depth of penetration. The long-pulsed Nd:YAG laser has been the ideal choice for lesions off the face and for thick or deep vascular targets, although newer short-pulsed high-energy (650-μs) devices are showing high efficacy and safety on facial vessels as well. Common uses include leg veins, port-wine stains, blue vessels, and venous lakes. Care must be taken to use adequate cooling during treatment. The Nd:YAG laser is a versatile wavelength with many possible uses for both pigmented and vascular indications. © 2014 S. Karger AG, Basel Vascular lesions, such as port-wine stains and hemangioma of infancy, have been the first and most evident uses for cutaneous lasers in dermatology. However, there are many other uses for these lasers, some vascular in nature and some using the same target, but for a different purpose. The shorter wavelength vascular lasers, including the pulsed dye laser, were the initial lasers implemented for these indications. Over the past 20 years, advancements including using other wavelengths, such as 532 nm [KTP (potassium-titanyl-phosphate)], 755 nm (alexandrite), and 1,064 nm [Nd:YAG (neodymium:yttrium-aluminum-garnet)] have expanded available treatments for these and other vascular conditions. The Nd:YAG laser has become a vital wavelength in treating many cutaneous conditions, including hemangiomas of infancy, port-wine stains, leg veins, venous lakes, telangiectasias scars and photorejuvenation.The first reports of the Nd:YAG laser being used for vascular lesions was in the early 1980s [1,2]. Parkin and Dixon [1] used an Nd:YAG laser to successfully photocoagulate intranasal telangiectasias in patients with Osler-Weber-Rendu syndrome. In 1986, the Nd:YAG was used on hypertrophic port-wine stains [3]. The fluence used was very high with no epidermal cooling, resulting in coagulation at a great depth, but with posttreatment necrosis of the epidermis and scarring [4]. Histologic investiga-

show abstract

“…Some severe hemangiomas with rapid proliferation may lead to serious dysfunction, and even be life-threatening. 2 Therefore, in recent years, more experts prefer treatments rather than observation.…”

mentioning

confidence: 99%

“…The incidence of hemangioma in the early neonatal is about 5%-10%, and 30% in preterm infants. 1,2 Although it is possible for infantile hemangioma to regress completely, about 40% to 50% of patients persist residual lesions, such as telangiectasias, scar, skin atrophy, fibrofatty tissue residues, and other beauty defects. 3,4 Clinically, there are still 20% to 30% of hemangiomas that cannot regress completely.…”

mentioning

confidence: 99%

Clinical Evaluation of Color Doppler Ultrasound in Selecting the Optimal Treatment Modality for Infantile Hemangioma△

Liu

Valeska

et al. 2017

Chinese Medical Sciences Journal

View full text Add to dashboard Cite

Infantile Hemangiomas Treated by Sequential Application of Pulsed Dye Laser and Nd:YAG Laser Radiation: A Retrospective Study

Cited by 24 publications

References 28 publications

Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children

Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children

Nd:YAG Laser

Clinical Evaluation of Color Doppler Ultrasound in Selecting the Optimal Treatment Modality for Infantile Hemangioma△

Contact Info

Product

Resources

About